RNS Number : 5270J

AorTech International PLC

19 August 2019

19 August 2019

AorTech International plc

("AorTech")

Result of AGM

AorTech International plc (AIM: AOR), the biomaterials IP and medical device development company, announces that all resolutions put to shareholders at its Annual General Meeting held earlier today, were duly passed.

For further information contact:

AorTech International plc

Tel: +44 (0)7730 718296

Bill Brown, Chairman

Shore Capital

Tel: +44 (0)20 7408 4080

Tom Griffiths/David Coaten

About AorTech:

AorTech has developed biostable, implantable polymers, including Elast-Eon™ and ECSil™ the world's leading long-term implantable co-polymers, now manufactured on its behalf by Biomerics LLC in Utah, USA. Elast-Eon™ and ECSil™'s biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. These polymers can be processed using conventional thermoplastic extrusion and moulding techniques. With over 6 million implants and over 10 years of successful clinical use AorTech polymers are proven in long term life enabling applications.

In addition to continuing to exploit AorTech's Intellectual Property related to the world class biomaterial - Elast-Eon™, AorTech is now incorporating this material into a number of medical devices of our own design. Elast-Eon™ has first class long term blood contacting properties and as a result, all of the initial products being developed are for the cardio vascular field. Each device is being designed to have improved clinical outcomes over current device technology,eliminating the use of animal sourced material whilst allowing procedures to remain the same, therefore avoiding the need of having to retrain surgeons in new ways of operating.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.comor visit www.rns.com.

END

RAGPLMJTMBABBBL

Page 1 of 1

Attachments

  • Original document
  • Permalink

Disclaimer

AorTech International plc published this content on 19 August 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 August 2019 14:11:02 UTC